Psychosis in Parkinson’s disease and polymorphisms of the HOMER1 and COMT genes: Is there an association?
Objective: To investigate if polymorphisms of the HOMER1 and COMT gene are associated with psychosis in Parkinson’s disease (PD). Background: Psychosis is one of the…The 20-item Noise Pareidolia Task is uniquely sensitive to Visual Hallucinations in Parkinson’s Disease
Objective: The purpose of this study was to examine clinical utility of the 20-item Noise Pareidolia Task (NPT20) in Parkinson’s disease (PD), as indicated by…Parkinson’s-disease risk variants are differentially associated with discrete phenotypic characteristics of Parkinson’s-disease at baseline.
Objective: Evaluate whether genetic risk variants for Parkinson’s disease discovered in case-control GWAS uniformly or differentially contribute to the clinical phenotype of PD. Background: Genetic…Clinical correlates of visual hallucinations in Parkinson’s disease
Objective: The aim of this study is to identify frequency and clinical (motor and nonmotor) correlates of VH predictors of their development after a follow-up…Parkinson’s disease patients with hallucinations exhibit dopaminergic degeneration and cortical thinning
Objective: Examine whether Parkinson’s disease patients (PD) who experience hallucinations (PD+hall) exhibit a greater decline in striatal dopamine and corresponding posterior cortical decline relative to…Homer1 polymorphism in patients with Parkinson’s disease and psychosis
Objective: To explore the association of psychosis in Parkinson’s disease with polymorphisms of HOMER1, a gene whose product (Homer1) is responsible for modulating the metabotropic…Increased illusory responses in non-hallucinating, cognitively impaired Lewy body disease patients
Objective: To determine whether non-hallucinating Lewy body disease-spectrum patients report increased illusory responses. Background: Pareidolias are specific illusions of faces and objects perceived in formless…Genetic risk scores and hallucinations in Parkinson’s disease patients
Objective: To examine the overlap of genetic architecture for Alzheimer’s disease (AD), schizophrenia (SZ), and PD with the genetic architecture for the occurrence of hallucinations…Management of neuropsychiatric symptoms in Parkinson’s disease (PD) at the front door
Objective: To ascertain the number of PD patients admitted to the acute hospital with neuropsychiatric symptoms requiring a review by PD specialist, including medicine reconciliation…Non-motor Symptoms in Advanced- vs Non-advanced Parkinson’s Disease: A Subgroup Analysis of the OBSERVE-PD Observational Study
Objective: To report intercountry differences in non-motor symptoms in patients with advanced Parkinson’s Disease (APD) vs non-APD. Background: There is no standard criteria for the…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 10
- Next Page »